{
  "item1": "majority U.S. Healthcare Solutions’ sales force led nationally, geographic focus specialized either healthcare provider type size. Customer service representatives centralized respond customer needs timely effective manner. U.S.",
  "item7": "ITEM 7. MANAGEMENT’S DISCUSSION ANALYSIS FINANCIAL CONDITION RESULTS OPERATIONS Management’s Discussion Analysis Financial Condition Results Operations (“MD&A”) includes following: overview provides summary segments highlights fiscal 2025; more detailed analysis results operations; capital resources liquidity, which discusses key aspects statements cash flows, changes balance sheets financial commitments; summary critical accounting estimates involve significant level estimation uncertainty. MD&A should read conjunction Consolidated Financial Statements notes thereto contained herein. one largest global pharmaceutical sourcing distribution services companies, helping both healthcare providers pharmaceutical biotech manufacturers improve patient access products enhance patient care.",
  "item2": "Multi-currency revolving credit facility due 2030 Receivables securitization facility due 2028 Term loan due 2027 Money market facility due 2027 Alliance Healthcare debt Total variable-rate debt $2.4 billion multi-currency senior unsecured revolving credit facility (\"Multi-Currency Revolving Credit Facility\") syndicate lenders, which scheduled expire October 2029. June 2025, amended restated Multi-Currency Revolving Credit Facility extend expiration June 2030 increase aggregate amount commitments thereunder $4.5 billion. Interest borrowings under Multi-Currency Revolving Credit Facility accrues specified rates based upon debt ratings. pay facility fees maintain availability under Multi-Currency Revolving Credit Facility specified rates based debt rating."
}